A Win For Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. (INO:NASDAQ) jumped higher at $0.51, a gain of 41%. On Tue, Oct 10, 2023, INO:NASDAQ hit a New 2-Week High of $0.51. The stock appeared on our News Catalysts scanner on Tue, Oct 10, 2023 at 09:14 AM in the 'BIOTECH' category. From Tue, Sep 26, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
About Inovio Pharmaceuticals, Inc. (INO:NASDAQ)
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
Top 10 Gainers:
- SuperCom Ltd. (SPCB:NASDAQ), 144.44%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 68.82%
- Signature Bank (SBNY:NASDAQ), 54.55%
- Prestige Wealth Inc. (PWM:NASDAQ), 54.07%
- Mobilicom Limited (MOB:NASDAQ), 44.37%
- Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 41%
- Senstar Technologies Ltd. (SNT:NASDAQ), 36.21%
- Esports Technologies Inc. (EBET:NASDAQ), 31.29%
- StarTek, Inc. (SRT:NYSE), 29.14%
- PowerFleet, Inc. (PWFL:NASDAQ), 28.43%